Role of Stents, Drug-Eluting Stents, and Stent-Grafts in Treatment of Infrainguinal Arterial Disease

Seminars in Vascular Surgery

Volumn 20, Issue 1, 2007, Pages 37-41

  Tang, Gale L ^a   Morasch, Mark D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METAL;

ANEURYSM; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; ARTICLE; BALLOON EXPANDABLE STENT; BIODEGRADABLE IMPLANT; DRUG ELUTING STENT; EQUIPMENT DESIGN; FEMORAL ARTERY; GRAFT PATENCY; GUIDE WIRE; HUMAN; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; POPLITEAL ARTERY; PRIORITY JOURNAL; RESTENOSIS; SELF EXPANDABLE STENT; STENT; STENT GRAFT; TIBIAL ARTERY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION;

ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; CONSTRICTION, PATHOLOGIC; FEMORAL ARTERY; HUMANS; PATIENT SELECTION; PERIPHERAL VASCULAR DISEASES; POPLITEAL ARTERY; PROSTHESIS DESIGN; RECURRENCE; STENTS; TIBIAL ARTERIES; TREATMENT OUTCOME;

EID: 33947411379     PISSN: 08957967     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2007.02.004     Document Type: Article

References (50)

1. Bradbury A.W., Ruckley C.V., Fowkes F.G.R., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 (2005) 1925-1234
2. Hirsch A.T., Haskal Z.J., and Hertzer N.R. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary. J Am Coll Cardiol 47 (2006) 1239-1312
3. Feinglass J., McCarthy W.J., Slavensky R., et al. Functional status and walking ability after lower extremity bypass grafting or angioplasty for intermittent claudication: results from a prospective outcomes study. J Vasc Surg 31 (2000) 93-103
4. Johnston K.W. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 183 (1992) 767-771
5. Becquemin J.-P., Favre J.-P., and Marzelle J. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg 37 (2003) 487-494
6. Scheinert D., Scheinert S., Sax J., et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45 (2005) 312-315
7. Rosenfield K., Schainfeld R., Pieczek A., et al. Restenosis of endovascular stents from stent compression. J Am Coll Cardiol 29 (1997) 328-338
8. Duda S.H., Pusich B., Richter G., et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 106 (2002) 1505-1509
9. Schlager O., Dick P., Sabeti S., et al. Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 12 (2005) 676-684
10. Balmer H., Mahler F., Do D.-D., et al. Balloon angioplasty in chronic critical limb ischemia: factors affecting clinical and angiographic outcome. J Endovasc Ther 9 (2002) 403-410
11. Treiman G.S., Treiman R.L., Ichikawa L., et al. Should percutaneous transluminal angioplasty be recommended for treatment of infrageniculate popliteal artery or tibioperoneal trunk stenosis?. J Vasc Surg 22 (1995) 457-465
12. Zdanowski Z., Albrechtsson U., Lundin A., et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions?. A randomized controlled study. Int Angiol 18 (1999) 251-255
13. Vroegindeweij D., Vos L.D., Tielbeek A.V., et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol 20 (1997) 420-425
14. Cejna M., Schoder M., and Lammer J. PTA vs. stent in femoro-popliteal obstruction. Radiologe 39 (1999) 144-150
15. Grimm J., Muller-Hulsbeck S., Jahnke T., et al. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol 12 (2001) 935-942
16. Sabeti S., Mlekusch W., Amighi J., et al. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther 12 (2005) 6-12
17. Duda S.H., Bosiers M., Lammer J., et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16 (2005) 331-338
18. Sabeti S., Schillinger M., Amighi J., et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology 232 (2004) 516-521
19. Lugmayr H.F., Holzer H., Kastner M., et al. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a midterm follow-up. Radiology 222 (2002) 37-43
20. Schillinger M., Sabeti S., Louie C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
21. Tepe G., Schmehl J., Heller S., et al. Superficial femoral artery: current treatment options. Eur Radiol 16 (2006) 1316-1322
22. Cepak P., McLean G.K., and Berkowitz H.D. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 83 (1991) I-70-I-80
23. Ahmadi R., Schillinger M., Maca T., et al. Femoropopliteal arteries: Immediate and long-term results with a Dacron-covered stent-graft. Radiology 223 (2002) 345-350
24. Jahnke T., Andresen R., Müller-Hülsbeck S., et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol 51 (2003) 41-51
25. Fischer M., Schwabe C., and Schulte K.-L. Value of the Hemobahn/Viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther 13 (2006) 281-290
26. Bonvini R, Baumgartner I, Do DD, et al: Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries. J Am Coll Cardiol 41:409-412.
27. Iida O., Nanto S., Uematsu M., et al. Cilostazol reduces target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery. Circ J 69 (2005) 1256-1259
28. Siauw R., Koh E.H., and Walker S.R. Endovascular repair of popliteal artery aneurysms: techniques, current evidence and recent experience. ANZ J Surg 76 (2006) 505-511
29. Antonello M., Frigatti P., Battocchio P., et al. Open repair versus endovascular treatment for asymptomatic popliteal artery aneurysm: results of a prospective randomized study. J Vasc Surg 42 (2005) 185-193
30. Dorros G., Jaff M.R., and Dorros A.M. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation 104 (2001) 2057-2062
31. Dorros G., Jaff M.R., Murphy K.J., et al. The acute outcome of tibioperoneal vessel angioplasty in 417 cases with claudication and critical limb ischemia. Cathet Cardiovasc Diagn 45 (1998) 251-256
32. Siablis D., Kraniotis P., Karnabatidis D., et al. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther 12 (2005) 685-695
33. Scheinert D., Ulrich M., Scheinert S., et al. Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. Eurointervention 2 (2006) 169-174
34. Commeau P., Barragan P., and Roquebert P.O. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Cathet Cardiovasc Interv 68 (2006) 793-798
35. Peeters P., Bosiers M., Verbist J., et al. Preliminary results after application of absorbable metal stents in patients with critical limb ischemia. J Endovasc Ther 12 (2005) 1-5
36. Myles O., Thomas W.J., Daniels J.T., et al. Infected endovascular stents managed with medical therapy alone. Cathet Cardiovasc Intervent 51 (2000) 471-476
37. Malek A.M., Higashida R.T., and Reilly L.M. Subclavian arteritis and pseudoaneurysm formation secondary to stent infection. Cardiovasc Intervent Radiol 23 (2000) 57-60
38. Antonios V.S., and Baddour L.M. Intra-arterial device infections. Curr Infect Dis Rep 6 (2004) 263-269
39. Hearn A.T., James K.V., Lohr J.M., et al. Endovascular stent infection with delayed bacterial challenge. Am J Surg 174 (1997) 157-159
40. Paget D.S., Bukhari R.H., Zayyat E.J., et al. Infectibility of endovascular stents following antibiotic prophylaxis or after arterial wall incorporation. Am J Surg 178 (1999) 219-224
41. Kirksey L., Brener B.J., Hertz S., et al. Prophylactic antibiotics prior to bacteremia decrease endovascular graft infection in dogs. Vasc Endovasc Surg 36 (2002) 171-178
42. Dravid V.S., Gupta A., Zegel H.G., et al. Investigation of antibiotic prophylaxis usage for vascular and nonvascular interventional procedures. J Vasc Interv Radiol 9 (1998) 401-406
43. Dosluoglu H.H., Curl G.R., Doerr R.J., et al. Stent-related iliac artery and iliac vein infections: two unreported presentations and review of the literature. J Endovasc Ther 8 (2001) 202-209
44. Ryan J.M., Ryan B.M., and Smith T.P. Antibiotic prophylaxis in interventional radiology. J Vasc Interv Radiol 15 (2004) 547-556
45. Bunt T.J., Gill H.K., Smith D.C., et al. Infection of a chronically implanted iliac artery stent. Ann Vasc Surg 11 (1997) 529-532
46. Guest S.S., Kirsch C.M., Baxter R., et al. Infection of a subclavian venous stent in a hemodialysis patient. Am J Kidney Dis 26 (1995) 377-380
47. Gordon G.I., Vogelzang R.L., Curry R.H., et al. Endovascular infection after renal artery stent placement. J Vasc Interv Radiol 7 (1996) 669-672
48. Bukhari R.H., Muck P.E., Schlueter F.J., et al. Bilateral renal artery stent infection and pseudoaneurysm formation. J Vasc Interv Radiol 11 (2000) 337-341
49. Brodmann M., Stark G., Pabst E., et al. Osteomyelitis of the spine and abscess formation in the left thigh after stent-graft implantation in the superficial femoral artery. J Endovasc Ther 7 (2000) 150-154
50. Walton K.B., Hudenko K., D'Ayala M., et al. Aneurysmal degeneration of the superficial femoral artery following stenting: an uncommon infectious complication. Ann Vasc Surg 17 (2003) 445-448